What is ABP's current stock price?

ABP (Abpro Corporation) is currently trading at $0.52 with a market cap of $1.1M.

What sector is Abpro Corporation in?

Abpro Corporation (ABP) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

ABP Abpro Corporation

Healthcare

$0.52+0.00%ClosedMarket Cap: $1.1M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

-0.04

P/S

3.22

EV/EBITDA

-0.03

DCF Value

$-16.17

FCF Yield

-2313.4%

Div Yield

0.0%

Margins & Returns

Gross Margin

-55.2%

Operating Margin

-7950.8%

Net Margin

-7670.5%

ROE

83.2%

ROA

-824.3%

ROIC

93.8%

Financials

View All

Period	Revenue	Net Income	EPS
Q3 null	$0.00	$-1.7M	$—
Q2 null	$0.00	$-3.0M	$—
Q1 null	$0.00	$-3.9M	$—
Q4 null	$183.0K	$-5.5M	$—

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy0 Buy1 Hold0 Sell0 Strong Sell

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

-0.00

Abpro Holdings, Inc., a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues. Its platform DiversImmune addresses a bottleneck in the antibody therapeutics industry. Its lead product candidates include ABP-100 for the treatment of breast, gastric, and colorectal cancers; and ABP-201 for the treatment of vascular diseases of the eye. The company has a strategic partnership with Abpro Bio Co. Ltd and NJCTTQ. The company was formerly known as Abpro Corporation and changed its name to Abpro Holdings, Inc. in November 2024. Abpro Holdings, Inc. was incorporated in 2004 and is headquartered in Woburn, Massachusetts.

Peers

APM